OneSkin
OneSkin is a longevity company developing products designed to extend skin and body health by targeting aging at its source.
About OneSkin
OneSkin is a longevity company on a mission to extend the health of your skin and body. Founded by a team of four PhDs and longevity scientists, they have identified a novel proprietary peptide, OS-01, which is the first compound validated to reduce your skin's biological age by decreasing the accumulation of aged cells, improving cellular repair capacity and strengthening the epidermal skin barrier. Their flagship product, OS-01 Topical Supplement is currently available through their website.
Company Facts
- Headquarters
- San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $46,562,714
- Last Funding Type
- series_a
- Last Funding Date
- 2025-08-06
- Website
- oneskin.co
Industries & Categories
Beauty, Biotechnology, Cosmetics, Health Care, Wellness
Social Links
Canonical: https://fsome.com/organization/oneskin-39890 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.